D-0097-2021 Class II Terminated
FDA drug recall D-0097-2021 was initiated by Ascent Pharmaceuticals, Inc. on Oct 26, 2020 and is designated Class II. Reason for recall: Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg. The recall status is terminated (terminated Feb 17, 2023). Affected quantity: 9768 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 25, 2020
- Initiation Date
- Oct 26, 2020
- Termination Date
- Feb 17, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9768 Bottles
Product description
Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Manufactured by: Ascent Pharmaceuticals, Inc. Central Islip, NY 11722, NDC 31722-943-01
Reason for recall
Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg.
Distribution pattern
Nationwide within the United States
Code information
Lot #: 20070518, Exp. Date June 2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0097-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026